USANA Health Sciences, Inc. (USNA)

Market Cap	648.41M
Revenue (ttm)	861.97M
Net Income (ttm)	54.34M
Shares Out	19.06M
EPS (ttm)	2.83
PE Ratio	12.02
Forward PE	12.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,625
Open	34.44
Previous Close	34.12
Day's Range	33.60 - 34.79
52-Week Range	31.44 - 52.75
Beta	0.89
Analysts	Hold
Price Target	38.00 (+11.7%)
Earnings Date	Feb 4, 2025

About USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement sh...

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: Jul 25, 1996
• Employees: 1,800
• Stock Exchange: NYSE
• Ticker Symbol: USNA
• Website: https://www.usana.com

Financial Performance

In 2023, USANA Health Sciences's revenue was $921.01 million, a decrease of -7.77% compared to the previous year's $998.60 million. Earnings were $63.79 million, a decrease of -8.02%.

Analyst Forecast

According to one analyst, the rating for USNA stock is "Hold" and the 12-month stock price forecast is $38.0.

Price Target

$38.0

(11.70% upside)

Analyst Consensus: Hold